Release Date: 16/02/16 08:48 Summary: Presentation Briefing Slides Price Sensitive: No Download Document 1.55MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%